Current Directions in Biomedical Engineering (Sep 2020)
Semi-automatic decision-making process in histopathological specimens from Barrett’s carcinoma patients using hyperspectral imaging (HSI)
Abstract
Discrimination of malignant and non-malignant cells of histopathologic specimens is a key step in cancer diagnostics. Hyperspectral Imaging (HSI) allows the acquisition of spectra in the visual and near-infrared range (500-1000nm). HSI can support the identification and classification of cancer cells using machine learning algorithms. In this work, we tested four classification methods on histopathological slides of esophageal adenocarcinoma. The best results were achieved with a Multi-Layer Perceptron. Sensitivity and F1-Score values of 90% were obtained.
Keywords